November 09, 2026 at 12:50 PM UTC
CorMedix Inc. reports material agreement in SEC 8-K
CorMedix Inc. filed an 8-K covering a material definitive agreement, a direct financial obligation, an unregistered sale of equity securities, and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 09, 2026 at 12:49 PM UTC
Open official source